World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
45712
World Ranking
8179
National Ranking
802

Overview

Richard A. C. Hughes is affiliated with University College London in the United Kingdom and has contributed extensively to the field of medicine with a focus on infectious diseases, immunology, pathology and forensic medicine, genetics, and oncology. Their research primarily addresses topics such as SARS-CoV-2 and COVID-19, biosimilars and bioanalytical methods, chronic lymphocytic leukemia, multiple sclerosis, immunodeficiency and autoimmune disorders, and autoimmune bullous skin diseases.

They have published research in several prominent venues, notably:

  • Neurology
  • Revue Neurologique
  • Multiple Sclerosis and Related Disorders
  • Bioanalysis
  • JAMA Network Open

Frequent co-authors of Richard A. C. Hughes include:

  • Stephen L. Hauser
  • Licínio Craveiro
  • Harold Koendgen
  • Annette Sauter
  • Tobias Derfuß

Their recent published papers include:

  • "Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis," 2021, Neurology
  • "COVID-19 in ocrelizumab-treated people with multiple sclerosis," 2020, Multiple Sclerosis and Related Disorders
  • "COVID-19 in persons with multiple sclerosis treated with ocrelizumab - A pharmacovigilance case series," 2020, Multiple Sclerosis and Related Disorders
  • "Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies," 2023, Neurology
  • "P36 Serum immunoglobulin levels and risk of serious infections in the pivotal phase III trials of ocrelizumab in multiple sclerosis and their open-label extensions," 2020, Clinical Neurophysiology

The researcher's work extensively covers multiple sclerosis, including treatment safety and COVID-19 implications for patients receiving ocrelizumab. Their investigations also intersect with pharmacovigilance and immunological responses tied to autoimmune and infectious diseases.

Best Publications

  • Neuropathic pain Redefinition and a grading system for clinical and research purposes

    R. D. Treede;T. S. Jensen;J. N. Campbell;G. Cruccu

  • Guillain-Barré syndrome

    Richard A C Hughes;David R Cornblath

  • CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY

    R.A.C. Hughes;J.M. Newsom-Davis;G.D. Perkin;J.M. Pierce

  • 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.

    Jessica E Hoogendijk;Anthony A Amato;Bryan R Lecky;Ernest H Choy

  • Electrophysiological classification of guillain-barré syndrome: Clinical associations and outcome

    R. D. M. Hadden;D. R. Cornblath;R. A. C. Hughes;J. Zielasek

  • Campylobacter jejuni infection and Guillain-Barré syndrome.

    Jeremy H. Rees;Sara E. Soudain;Norman A. Gregson;Richard A.C. Hughes

  • Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.

    Michael P T Lunn;Richard A C Hughes;Philip J Wiffen

  • Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

    Richard A C Hughes;Peter Donofrio;Vera Bril;Marinos C Dalakas

  • Intravenous immunoglobulin for Guillain-Barré syndrome

    Richard A C Hughes;Anthony V Swan;Pieter A van Doorn

  • Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

    James J. Sejvar;Katrin S. Kohl;Jane Gidudu;Anthony Amato

  • Epidemiology of peripheral neuropathy.

    C. N. Martyn;R. A. C. Hughes

  • Enhanced glucose control for preventing and treating diabetic neuropathy

    Brian C Callaghan;Ann A Little;Eva L Feldman;Richard A C Hughes

  • Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy

    R Hughes;Peter Van den Bergh;S Bensa;H Willison

  • Diagnosis and management of Guillain–Barré syndrome in ten steps

    Sonja E. Leonhard;Melissa R. Mandarakas;Francisco A. A. Gondim;Kathleen Bateman

  • Clinical and Epidemiologic Features of Guillain-Barré Syndrome

    Richard A. C. Hughes;Jeremy H. Rees

  • European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision

    Robert D. Hadden;Eduardo Nobile-Orazio;Claudia Sommer;Angelika Hahn

  • Immunotherapy for Guillain-Barré syndrome: A systematic review

    Richard A C Hughes;Anthony V Swan;Jean-Claude Raphaël;Djillali Annane

  • Pathogenesis Of Guillain-Barre Syndrome

    R.A.C. Hughes;R.D.M. Hadden;N.A. Gregson;K.J. Smith

  • Preceding infections, immune factors, and outcome in Guillain-Barré syndrome

    R.D.M. Hadden;R.D.M. Hadden;H. Karch;H.-P. Hartung;H.-P. Hartung;J. Zielasek

  • Plasma exchange for Guillain‐Barré syndrome

    Jean Claude Raphaël;Sylvie Chevret;Richard A C Hughes;Djillali Annane

Frequent Co-Authors

David R. Cornblath
David R. Cornblath Johns Hopkins University School of Medicine
Hugh J. Willison
Hugh J. Willison University of Glasgow
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Marinos C. Dalakas
Marinos C. Dalakas Thomas Jefferson University
Norman Latov
Norman Latov Cornell University
Kenneth Smith
Kenneth Smith University of Nottingham
Irene J Higginson
Irene J Higginson King's College London
P.A. van Doorn
P.A. van Doorn Erasmus University Rotterdam
Claudia Sommer
Claudia Sommer University of Würzburg
Bart C. Jacobs
Bart C. Jacobs Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternatives to traditional medical degrees can open more flexible and accessible career options in healthcare. Many students interested in medical fields start with roles such as medical billing and coding. For those needing financial support, medical billing and coding schools that accept financial aid offer pathways to begin a healthcare career without overwhelming debt.

Nursing is another attractive entry point, but there can be barriers like entrance exams. If you’re concerned about the TEAS test, discover the answer to do I need to take the TEAS test for LPN and find schools with less restrictive admissions processes.

For those aiming to advance quickly, accelerated healthcare programs can help you earn your degree faster, getting you into the workforce or leadership roles sooner. Experienced nurses interested in advanced practice roles can look to RN to NP programs for streamlined routes from associate degrees to nurse practitioner licensure.

Each of these online pathways provides flexibility, financial aid opportunities, and clear routes for career advancement in the healthcare sector.

Best Scientists Citing Richard A. C. Hughes

Trending Scientists

Recently Published Articles